Oramorph and aspartate aminotransferase increased Patient Reports February 13, 2012

Oramorph Side Effects Report #5730200-X
Oramorph side effect was reported by a Health Professional from UNITED KINGDOM on Apr 18, 2008. Female patient, 43 years of age, was diagnosed with pain , breast cancer metastatic and was treated with Oramorph. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, dehydration, dyspnoea, hyponatraemia, hypotension, nausea , oral intake reduced. Oramorph dosage: unknown. During the same period patient was treated with LAPATINIB, CAPECITABINE. Patient was hospitalized. Patient died on 04/02/2008.